phenolsulfonphthalein has been researched along with mifepristone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardon, S; Derocq, D; Gill, PG; Rochefort, H; Vignon, F | 1 |
Agostini, S; Broccardo, M; Del Bianco, P; Improta, G; Petrella, C; Scaccianoce, S | 1 |
2 other study(ies) available for phenolsulfonphthalein and mifepristone
Article | Year |
---|---|
Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Estradiol; Estrenes; Glucocorticoids; Humans; Mifepristone; Norpregnadienes; Phenolsulfonphthalein; Promegestone; Protein Biosynthesis; Receptors, Estrogen; Tumor Cells, Cultured | 1987 |
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Coloring Agents; Corticosterone; Corticotropin-Releasing Hormone; Gastric Emptying; Hormone Antagonists; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Male; Mifepristone; Nociceptin; Opioid Peptides; Peptide Fragments; Phenolsulfonphthalein; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid | 2005 |